Jacquelyn Sandell
General Counsel at JOUNCE THERAPEUTICS, INC.
Net worth: 682 640 $ as of 2024-04-29
Jacquelyn Sandell active positions
Companies | Position | Start | End |
---|---|---|---|
JOUNCE THERAPEUTICS, INC. | General Counsel | 2019-09-16 | - |
Corporate Secretary | 2019-09-16 | - | |
VOYAGER THERAPEUTICS, INC. | General Counsel | 2023-07-09 | - |
Career history of Jacquelyn Sandell
Former positions of Jacquelyn Sandell
Companies | Position | Start | End |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2010-12-31 | 2014-12-31 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 2004-12-31 | 2010-12-31 |
VERICEL CORPORATION | General Counsel | 2014-12-31 | - |
Training of Jacquelyn Sandell
Duke University | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Statistics
International
United States | 8 |
Operational
General Counsel | 4 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
VERICEL CORPORATION | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Jacquelyn Sandell
- Experience